Novavax (NVAX) Revenue
Novavax Revenue
Novavax had a revenue of 56.70M in the quarter ending Jun 30, 2026, with -59.36%. This bring the company's revenue in the last twelve months to 413.80M, Decreased 30.61%. In the fiscal year ending Dec 31, 2025, Novavax had annual revenue of 1.12B with 64.69% growth.
- Revenue (ttm)
- 413.80M
- Revenue Growth
- -65.63%
- P/S Ratio
- 27.81
- Revenue/Employee
- MXN 1,499,972
- Employees
- 749
- Market Cap
- MXN 31.24B
Revenue Chart
Novavax Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12B | 441.32M | 64.69% |
| Dec 31, 2024 | 682.16M | 125.78M | 22.61% |
| Dec 31, 2023 | 556.38M | -1.04B | -65.20% |
| Dec 31, 2022 | 1.60B | 1.40B | 709.26% |
| Dec 31, 2021 | 197.58M | 175.19M | 782.53% |
| Dec 31, 2020 | 22.39M | 3.73M | 19.97% |
| Dec 31, 2019 | 18.66M | -15.63M | -45.57% |
| Dec 31, 2018 | 34.29M | 3.11M | 9.98% |
| Dec 31, 2017 | 31.18M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| MX:NVAX | 413.80M |